Clinical Drug Experience Knowledgebase

Ataxia (Phase 2)

Breast Neoplasms (Phase 4)

Carcinoma (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Cerebellar Ataxia (Phase 2)

Colorectal Neoplasms (Phase 3)

Diabetic Retinopathy (Phase 3)

Dwarfism, Pituitary (Phase 4)

Emergence Delirium (Phase 1)

Endocrine System Diseases (Phase 4)

Essential Hypertension (Phase 3)

Hyperhomocysteinemia (Phase 3)

Hypertension (Phase 4)

Hyperuricemia (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, T-Cell (Phase 2)

Multiple Sclerosis (Phase 2)

Neoplasms (Phase 2)

Neuromyelitis Optica (Phase 2)

Peritoneal Neoplasms (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Psychomotor Agitation (Phase 1)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Retinal Diseases (Phase 3)

Sclerosis (Phase 2)

Spinocerebellar Degenerations (Phase 2)

Stomach Neoplasms (Phase 2)